Mail

Canada markets close in 2 hours 35 minutes

S&P/TSX
18,627.27
-206.89(-1.10%)
S&P 500
3,828.59
-2.80(-0.07%)
DOW
30,891.56
-76.26(-0.25%)
CAD/USD
0.7665
-0.0010(-0.13%)
CRUDE OIL
98.00
-1.50(-1.51%)
BTC-CAD
26,451.94
+657.47(+2.55%)

MARKETS LIVE BLOG

STOCKS RETREAT AS GROWTH CONCERNS GRIP MARKETS

U.S. service sector index at 2-year low, employment shrinks: ISM survey

Oncology Pharma Inc. (ONPH)

Other OTC - Other OTC Delayed Price. Currency in USD

Add to watchlist

1.5741

+0.1641

(+11.64%)

As of 01:05PM EDT. Market open.

Trade prices are not sourced from all markets

Previous Close	1.4100
Open	1.4300
Bid	N/A x N/A
Ask	N/A x N/A
Day's Range	1.4000 - 1.7600
52 Week Range	1.3100 - 31.9900
Volume	111,612
Avg. Volume	56,005

Market Cap	1.832M
Beta (5Y Monthly)	-1.86
PE Ratio (TTM)	N/A
EPS (TTM)	N/A
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

All

ACCESSWIRE
Oncology Pharma Conducting All The Preparations to Take Steps to Forward The Development Process of Nanoemulsion Drug Delivery System
SAN FRANCISCO, CA / ACCESSWIRE / June 29, 2022 / Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc.
ACCESSWIRE
Oncology Pharma Announces: Initial Feasibility Study of the Nanoemulsion Drug Delivery System is Complete and Results Have Met the Threshold for Moving Forward To the Next Steps of Development
SAN FRANCISCO, CA / ACCESSWIRE / June 8, 2022 / Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc.
ACCESSWIRE
Oncology Pharma Advances Progress on Multiple Fronts Including Advanced Attention to Connect2Trials' Commercial Development
SAN FRANCISCO, CA / ACCESSWIRE / May 9, 2022 / Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc.